May 21, 2020 / 8:33 PM / 9 days ago

BRIEF-HLS Therapeutics Supports Trial To Investigate Effects Of Vascepa Against COVID-19

May 21 (Reuters) - HLS Therapeutics Inc:

* HLS THERAPEUTICS SUPPORTS TRIAL TO INVESTIGATE THE EFFECTS OF VASCEPA® (ICOSAPENT ETHYL) AGAINST COVID-19

* HLS THERAPEUTICS INC - IN COLLABORATION WITH AMARIN, IT IS SUPPORTING A TRIAL TO INVESTIGATE EFFECTS OF VASCEPA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below